JNJ-26481585 |
|
(CAS 875320-29-9) |
 |
Description: |
Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7.
An orally bioavailable, second-generation, hydroxamic acid-based HDAC inhibitor.
|
Product No. |
KT00468 |
Product Name |
JNJ-26481585 |
Synonyms |
Quisinostat |
Formal Name |
|
CAS Number |
875320-29-9 |
Molecular Formula |
C21H26N6O2 |
Formula Weight |
394.476 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Nexturastat A
RG2833 (RGFP109)
TMP269
Vorinostat (SAHA, MK0683)
Panobinostat (LBH589)
Entinostat (MS-275)
Trichostatin A (TSA)
Romidepsin (FK228, Depsipeptide)
RGFP966
|
|